Oneness Biotech Co., Ltd. (LUX:ONES)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
10.20
+0.40 (4.08%)
At close: May 12, 2025

Oneness Biotech Revenue

Oneness Biotech had revenue of 25.22M TWD in the quarter ending March 31, 2025, a decrease of -2.30%. This brings the company's revenue in the last twelve months to 117.33M, up 29.78% year-over-year. In the year 2024, Oneness Biotech had annual revenue of 117.93M with 35.89% growth.

Revenue (ttm)
117.33M TWD
Revenue Growth
+29.78%
P/S Ratio
264.14
Revenue / Employee
2.73M TWD
Employees
43
Market Cap
861.76M EUR

Revenue Chart

* This company reports financials in TWD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024117.93M31.14M35.89%
Dec 31, 202386.78M-978.77M-91.86%
Dec 31, 20221.07B999.79M1,520.24%
Dec 31, 202165.77M24.16M58.07%
Dec 31, 202041.61M28.13M208.76%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reinet Investments S.C.A. 1.04B
Luxempart 50.29M
CPI FIM 147.67M
Socfinasia 186.43M
Socfinaf 591.38M
Velcan Holdings 2.95M
GP Investments -20.08M
Revenue Rankings